1. Home
  2. CSPI vs RANI Comparison

CSPI vs RANI Comparison

Compare CSPI & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

HOLD

Current Price

$13.01

Market Cap

132.8M

Sector

Technology

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.40

Market Cap

134.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSPI
RANI
Founded
1968
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.8M
134.6M
IPO Year
1987
2021

Fundamental Metrics

Financial Performance
Metric
CSPI
RANI
Price
$13.01
$1.40
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.67
AVG Volume (30 Days)
23.2K
2.6M
Earning Date
12-16-2025
11-06-2025
Dividend Yield
0.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,730,000.00
$1,200,000.00
Revenue This Year
N/A
$414.59
Revenue Next Year
N/A
$30.15
P/E Ratio
N/A
N/A
Revenue Growth
6.36
N/A
52 Week Low
$9.65
$0.39
52 Week High
$21.95
$3.87

Technical Indicators

Market Signals
Indicator
CSPI
RANI
Relative Strength Index (RSI) 51.63 42.10
Support Level $12.74 $1.40
Resistance Level $13.78 $1.53
Average True Range (ATR) 0.96 0.11
MACD -0.10 -0.00
Stochastic Oscillator 30.79 15.00

Price Performance

Historical Comparison
CSPI
RANI

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: